Iovance Biotherapeutics Inc (IOVA)

$2.23 +0.29 (14.95%)
Market Cap 671.21M
Revenue (ttm) 164.07M
Net Income (ttm) -372.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -226.84%
Debt to Equity Ratio 0.00
Volume 24,600,199
Avg Vol 15,404,200
Day's Range N/A - N/A
Shares Out 333.93M
Stochastic %K 55%
Beta 0.85
Analysts Strong Sell
Price Target $10.70

Company Profile

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States. The company offers Amtagvi, a tumor-derived autologous T cell immunotherapy used to treat adult patients with unresectable or metastatic melanoma; and Proleukin, an interleukin-2 product for the treatment of patients with metastatic melanom...

Industry: Biotechnology
Sector: Healthcare
Phone: (650) 260-7120
Address:
825 Industrial Road, Suite 100, San Carlos, United States
dogbone98
dogbone98 Jul. 16 at 10:52 PM
$IOVA Will be nice to learn the CAT decision after the meeting ends Friday. If CAT approves it, all else is rubber-stamping for EU approval. I imagine IOVA management already knows.
0 · Reply
Hankcat
Hankcat Jul. 16 at 10:50 PM
$IOVA For those playing at home. That was a quintuple bottom with lows at 1.65, 1.64, 1.67, 1.66 and yesterday's manufactured low of 1.70. The MACD is about to turn positive. Finished above the 10, 20 and 50dma Finished above the upper Bollinger Band I think this one is going to stick going into next earnings where all hell is going to break loose as ALL numbers will beat. Most important...revenues and margins.
1 · Reply
Ixnay84
Ixnay84 Jul. 16 at 10:38 PM
$IOVA nice move... tomorrow we need to see another green close, above the resistance of $2.24... today we almost did it, but its called resistance for a reason... some more news and we could just blow through most of the key levels before ER... Lets go...
0 · Reply
bhcapital
bhcapital Jul. 16 at 10:34 PM
$IOVA the market becomes less mysterious the longer I watch it. Even that price target, in reality it appears to have just confirmed at least the short term bottom. How many sold though? Or got stop losses triggered. Probably a lot which is where the liquidity came from, but that could also imply someone wanted to buy in, and needed extra liquidity to do so without pumping the stock like today.
0 · Reply
Bulltrader988
Bulltrader988 Jul. 16 at 10:34 PM
$IOVA reversal ongoing 👃👀
0 · Reply
EmbraceVolatility
EmbraceVolatility Jul. 16 at 10:16 PM
$IOVA Test of $2.40s incoming
0 · Reply
HamBoneXoXo
HamBoneXoXo Jul. 16 at 10:00 PM
$IOVA Clovis II
1 · Reply
Elementaryitis
Elementaryitis Jul. 16 at 10:00 PM
$IOVA
0 · Reply
tedevan
tedevan Jul. 16 at 10:00 PM
$IOVA
0 · Reply
billyl
billyl Jul. 16 at 9:42 PM
$IOVA after GS July 15 downgraded from 8 to $1 Today’s volume =24.6m 90 day Avg volume 12.6m Daily low - high =>1.92 to 2.25, closed 2.23+14.95% Multiple recent insider buys… They may sell for various reasons but they buy for only 1 reason.. bullish!! Based on most recent SEC Form 4 filings: • June 5, 2025 – Chief Commercial Officer Daniel Gordon Kirby acquired 30,000 shares at $1.84 per share ($55,200) . • May 23, 2025 – Chief Regulatory Officer Raj K. Puri purchased 5,600 shares at around $1.74 ($9,743) . • May 14, 2025 – Interim CEO & General Counsel Frederick G. Vogt bought 25,000 shares at $1.69 per share ($42,250)
0 · Reply
Latest News on IOVA
Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

Jul 15, 2025, 7:30 AM EDT - 1 day ago

Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV

Jul 14, 2025, 9:04 AM EDT - 2 days ago

IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV

Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma

Jul 14, 2025, 7:30 AM EDT - 2 days ago

Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jul 11, 2025, 10:32 AM EDT - 5 days ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D.

Jul 10, 2025, 4:01 PM EDT - 6 days ago

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D.

IOVA COURT NOTICE: Iovance Biotherapeutics Investors may have been Affected by Fraud – Contact BFA Law by the July 14 Legal Deadline (NASDAQ:IOVA)

Jul 10, 2025, 8:18 AM EDT - 6 days ago

IOVA COURT NOTICE: Iovance Biotherapeutics Investors may have been Affected by Fraud – Contact BFA Law by the July 14 Legal Deadline (NASDAQ:IOVA)

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jul 3, 2025, 7:35 AM EDT - 13 days ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure– Hagens Berman

Jul 2, 2025, 5:46 PM EDT - 14 days ago

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure– Hagens Berman

IOVA INVESTOR DEADLINE: Iovance Biotherapeutics Investors with Losses may have been Affected by Fraud – Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 28, 2025, 7:46 AM EDT - 18 days ago

IOVA INVESTOR DEADLINE: Iovance Biotherapeutics Investors with Losses may have been Affected by Fraud – Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit – IOVA

Jun 26, 2025, 4:45 PM EDT - 20 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit – IOVA

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit - IOVA

Jun 26, 2025, 9:00 AM EDT - 20 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 14, 2025 in Iovance Lawsuit - IOVA

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Jun 24, 2025, 12:03 PM EDT - 22 days ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Iovance Biotherapeutics

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Jun 23, 2025, 4:05 PM EDT - 23 days ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

IOVA COURT REMINDER: Iovance Biotherapeutics, Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 20, 2025, 9:07 AM EDT - 26 days ago

IOVA COURT REMINDER: Iovance Biotherapeutics, Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure – Hagens Berman

Jun 18, 2025, 2:34 PM EDT - 4 weeks ago

Iovance's (IOVA) CFO Resigns Amid Launch Setbacks and Legal Pressure – Hagens Berman

IOVA NOTICE: Did Iovance Biotherapeutics, Inc. Mislead Investors? Contact BFA Law by July 14 Court Deadline if You Suffered Losses (NASDAQ:IOVA)

Jun 18, 2025, 8:38 AM EDT - 4 weeks ago

IOVA NOTICE: Did Iovance Biotherapeutics, Inc. Mislead Investors? Contact BFA Law by July 14 Court Deadline if You Suffered Losses (NASDAQ:IOVA)

IOVA SHAREHOLDER REPORT: Iovance Biotherapeutics, Inc. was Sued for Fraud – Investors with Losses are Notified to Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 16, 2025, 8:17 AM EDT - 4 weeks ago

IOVA SHAREHOLDER REPORT: Iovance Biotherapeutics, Inc. was Sued for Fraud – Investors with Losses are Notified to Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

IOVA LEGAL NOTICE: Lose Money when Iovance Biotherapeutics, Inc. Stock Plummeted 44%? Contact BFA Law by the July 14 Court Deadline (NASDAQ:IOVA)

Jun 10, 2025, 8:47 AM EDT - 5 weeks ago

IOVA LEGAL NOTICE: Lose Money when Iovance Biotherapeutics, Inc. Stock Plummeted 44%? Contact BFA Law by the July 14 Court Deadline (NASDAQ:IOVA)

Iovance Biotherapeutics to Present at Upcoming Conference

Jun 10, 2025, 8:45 AM EDT - 5 weeks ago

Iovance Biotherapeutics to Present at Upcoming Conference

IOVA INVESTOR NEWS: Iovance Biotherapeutics, Inc. has been Sued for Securities Fraud – Contact BFA Law before July 14 Deadline (NASDAQ:IOVA)

Jun 8, 2025, 8:18 AM EDT - 5 weeks ago

IOVA INVESTOR NEWS: Iovance Biotherapeutics, Inc. has been Sued for Securities Fraud – Contact BFA Law before July 14 Deadline (NASDAQ:IOVA)

IOVA LAWSUIT: Iovance Biotherapeutics, Inc. Lawsuit Alleges Securities Fraud Violations - Investors Notified to Contact BFA Law

Jun 4, 2025, 3:46 PM EDT - 6 weeks ago

IOVA LAWSUIT: Iovance Biotherapeutics, Inc. Lawsuit Alleges Securities Fraud Violations - Investors Notified to Contact BFA Law

IOVA STOCK NOTICE: Iovance Biotherapeutics, Inc. Has Been Sued for Fraud; Investors Are Notified to Contact BFA Law Before July 14 Legal Deadline

Jun 3, 2025, 3:33 PM EDT - 6 weeks ago

IOVA STOCK NOTICE: Iovance Biotherapeutics, Inc. Has Been Sued for Fraud; Investors Are Notified to Contact BFA Law Before July 14 Legal Deadline

The Journal of Clinical Oncology Publishes Five-year Analysis of Amtagvi® (lifileucel) in Patients with Advanced Melanoma

Jun 2, 2025, 9:29 AM EDT - 6 weeks ago

The Journal of Clinical Oncology Publishes Five-year Analysis of Amtagvi® (lifileucel) in Patients with Advanced Melanoma

dogbone98
dogbone98 Jul. 16 at 10:52 PM
$IOVA Will be nice to learn the CAT decision after the meeting ends Friday. If CAT approves it, all else is rubber-stamping for EU approval. I imagine IOVA management already knows.
0 · Reply
Hankcat
Hankcat Jul. 16 at 10:50 PM
$IOVA For those playing at home. That was a quintuple bottom with lows at 1.65, 1.64, 1.67, 1.66 and yesterday's manufactured low of 1.70. The MACD is about to turn positive. Finished above the 10, 20 and 50dma Finished above the upper Bollinger Band I think this one is going to stick going into next earnings where all hell is going to break loose as ALL numbers will beat. Most important...revenues and margins.
1 · Reply
Ixnay84
Ixnay84 Jul. 16 at 10:38 PM
$IOVA nice move... tomorrow we need to see another green close, above the resistance of $2.24... today we almost did it, but its called resistance for a reason... some more news and we could just blow through most of the key levels before ER... Lets go...
0 · Reply
bhcapital
bhcapital Jul. 16 at 10:34 PM
$IOVA the market becomes less mysterious the longer I watch it. Even that price target, in reality it appears to have just confirmed at least the short term bottom. How many sold though? Or got stop losses triggered. Probably a lot which is where the liquidity came from, but that could also imply someone wanted to buy in, and needed extra liquidity to do so without pumping the stock like today.
0 · Reply
Bulltrader988
Bulltrader988 Jul. 16 at 10:34 PM
$IOVA reversal ongoing 👃👀
0 · Reply
EmbraceVolatility
EmbraceVolatility Jul. 16 at 10:16 PM
$IOVA Test of $2.40s incoming
0 · Reply
HamBoneXoXo
HamBoneXoXo Jul. 16 at 10:00 PM
$IOVA Clovis II
1 · Reply
Elementaryitis
Elementaryitis Jul. 16 at 10:00 PM
$IOVA
0 · Reply
tedevan
tedevan Jul. 16 at 10:00 PM
$IOVA
0 · Reply
billyl
billyl Jul. 16 at 9:42 PM
$IOVA after GS July 15 downgraded from 8 to $1 Today’s volume =24.6m 90 day Avg volume 12.6m Daily low - high =>1.92 to 2.25, closed 2.23+14.95% Multiple recent insider buys… They may sell for various reasons but they buy for only 1 reason.. bullish!! Based on most recent SEC Form 4 filings: • June 5, 2025 – Chief Commercial Officer Daniel Gordon Kirby acquired 30,000 shares at $1.84 per share ($55,200) . • May 23, 2025 – Chief Regulatory Officer Raj K. Puri purchased 5,600 shares at around $1.74 ($9,743) . • May 14, 2025 – Interim CEO & General Counsel Frederick G. Vogt bought 25,000 shares at $1.69 per share ($42,250)
0 · Reply
ONLYPHARMS
ONLYPHARMS Jul. 16 at 9:39 PM
$IOVA I have a couple positions I would like to add too….. I wonder if GS is taking requests?
1 · Reply
DGANG3
DGANG3 Jul. 16 at 9:29 PM
$IOVA Looks like the SHORTS are taking a controlled exit. It's about time! Screw Goldman!
0 · Reply
Gettingtillywithit
Gettingtillywithit Jul. 16 at 9:29 PM
$IOVA is there a pos article I missed?
0 · Reply
Jay_Bingo
Jay_Bingo Jul. 16 at 9:23 PM
$IOVA A 30 year veteran CFO decided to join without asking "what are your infusions in April and May"? She deicdes join the sinking ship. I got it. Also Marc. He realized lung data is disappointing but decided take a dip anyway after decades of experience in FDA biologics. Make total senses. Tie this with GS hit piece. Who is manipulating?
3 · Reply
HorizonBull
HorizonBull Jul. 16 at 9:23 PM
$IOVA
0 · Reply
Strategy2019
Strategy2019 Jul. 16 at 9:21 PM
$IOVA We are talking about a decrease in sales revenues & higher cost = Running out of money. Sales team is not able to Do a good job ???!!!
3 · Reply
Dark_Horse_Investments
Dark_Horse_Investments Jul. 16 at 9:12 PM
$IOVA so what is the final verdict on today's action: a) good analysis of 49% ORR on real world data ; b) hiring of new cfo and vp regulatory ; c) or just plain ol fomo reaction ? It was good healthy reaction. Kindly share any substantive thoughts. THX in advance
3 · Reply
Always_neutral
Always_neutral Jul. 16 at 9:11 PM
$IOVA You sold, go away or are you feeling left out🤣
3 · Reply
Strategy2019
Strategy2019 Jul. 16 at 9:08 PM
$IOVA Out of money in less than a year because of very expensive New staff (CFO, New FED guy...)
1 · Reply
WarrenDouglasTrader
WarrenDouglasTrader Jul. 16 at 9:07 PM
$IOVA If they ever announce a solution to their cash problem then we run like a freight train. Elephant in the room——out of money in a year
2 · Reply
Strategy2019
Strategy2019 Jul. 16 at 9:04 PM
$IOVA Next news on 8th of August. This means a very long time. Too long to invest in upward trend!
2 · Reply
Kobe2324
Kobe2324 Jul. 16 at 9:02 PM
$IOVA someone give me a valid reason for the move up today?
5 · Reply